Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesTowards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imagingInfluence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.Heritability and responses to high fat diet of plasma lipidomics in a twin study.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot studyIntegrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.Alterations of plasma lysophosphatidylcholine species in obesity and weight loss.Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and deathPlasma sphingosine-1-phosphate is elevated in obesityInclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes.Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome PatientsModulation of the lipidomic profile due to a lipid challenge and fitness level: a postprandial study.Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat DietComparison of Metabolites Variation and Antiobesity Effects of Fermented versus Nonfermented Mixtures of Cudrania tricuspidata, Lonicera caerulea, and Soybean According to Fermentation In Vitro and In Vivo.Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in Women.System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemiaTargeted metabolomics finds its mark in diabetes researchMetabolic Profiles Distinguish Non-Dampness-Phlegm and Dampness-Phlegm Patterns among Korean Patients with Acute Cerebral Infarction.Biomolecular signatures of diabetic wound healing by structural mass spectrometry.Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation.Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam studyGlycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.Mass Spectrometry-Based Metabolomic and Lipidomic Analyses of the Effects of Dietary Platycodon grandiflorum on Liver and Serum of Obese Mice under a High-Fat Diet.Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults.Lipidomics in nutrition and food research.Lipidomics applications in health, disease and nutrition research.The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents.Lipidomic analysis of serum from high fat diet induced obese mice.Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Alterations of specific lipid groups in serum of obese humans: a review.Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach.Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals.
P2860
Q26741550-5FB29E6F-7D2E-43F4-8170-C657E7DEE1B7Q28393497-3B66E4A4-E68C-4ADB-8763-71E52F756471Q33718016-E5B30CA3-D7A1-472B-A3A0-A77FAC360E77Q33807858-70FFDF94-7E46-4370-AEBA-E102B99E1D48Q33825153-5504D52A-01A1-4934-B52F-BAD528222136Q33896092-E15BF7BA-05E6-43CA-B9F7-A49371EAFF8CQ34339449-73B82BA4-1916-4205-8E6C-945521833009Q34395775-B322D920-E92D-49F9-AC78-DC4E4F12DC9FQ34734762-33C1D236-5D7B-49FD-BB08-477854630771Q34988407-65187024-7E50-4805-B4F6-75BB4DFE7F9DQ35014728-B61056F9-24AE-467E-98EE-A2B46814B381Q35806849-2B3ACD50-1E3A-4F65-9DF2-72994CF82B53Q35809565-9857BBFD-2928-463E-ADE5-B042985F0FC8Q35848129-F87708D6-F7A8-441D-AFC4-3A922EAC2ECCQ35915425-21F42BE7-3453-4332-B935-266DA88AAFF8Q36056872-95CE13A3-4964-409A-A1A1-C46965504536Q36333298-CD17A539-0615-400D-86A1-5F8C6C54954EQ36560506-B0D1B4F3-516B-4E3D-AE5A-CAB16EAACDB9Q36729156-9A5FFBC6-16E1-4AE0-909F-AECCB5E7C229Q36754130-CDDA1900-30C3-420F-BD35-BD106D7C1C24Q36788837-7CADE7DB-2588-4C8D-8642-DC026AA2CC54Q36863295-7B3C33F3-61BD-40AA-8C01-F74179DEAEAEQ37061182-463654EF-6FFA-40CC-AC65-13642DAF271BQ37490790-59507234-A9BD-4EEC-A6E8-BC60E4A78C8CQ37612293-1335EFC2-41A8-4AB7-9CA2-C80521546FBAQ37628465-5F529222-96C1-4CF9-93B0-0AD7ECE6DF79Q37716371-B40EF367-2F4E-470C-B408-49C2D9D585D5Q37726891-36D3A6AB-CBF3-45A9-A5F2-7E464CFF04EDQ38081867-A8308DDD-0D0B-4387-9A89-2B56EE8772D7Q38111301-04D8F031-D49E-41B3-A54F-248B7B2978FAQ38247935-F7ACB706-A0AE-43F8-995F-BCEB3DAD375AQ38345748-A4D41057-77EF-4691-9180-509E430F2277Q38445925-843D2D6D-88B4-4AB6-982E-508BFA7F6F62Q38460480-B1054CCD-55CB-42D0-9CD1-2A097876914DQ39023727-436AB558-B320-4309-9EB9-8ACC36147E83Q39288685-7430ED4D-C867-4047-8A50-870B67E8ABDCQ39608479-00D7EAB0-84AE-4AA5-A497-C3D2C5515350Q40109903-B02AC2E3-31B0-44E4-B09F-DA9B24F2831FQ40606450-AFA82976-F8E6-4B3A-9619-564030849A84Q41726561-D0AF0846-E301-4DEA-A2CF-3DE19BB67A05
P2860
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@ast
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@en
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@nl
type
label
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@ast
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@en
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@nl
prefLabel
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@ast
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@en
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes
@en
P2093
Christine Yang
Margaret Staples
Mark A Febbraio
Melissa N Barber
Steve Risis
P2860
P304
P356
10.1371/JOURNAL.PONE.0041456
P407
P577
2012-07-25T00:00:00Z